These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 9273826)

  • 21. Early rheumatoid arthritis treated with tocilizumab, methotrexate, or their combination (U-Act-Early): a multicentre, randomised, double-blind, double-dummy, strategy trial.
    Bijlsma JWJ; Welsing PMJ; Woodworth TG; Middelink LM; Pethö-Schramm A; Bernasconi C; Borm MEA; Wortel CH; Ter Borg EJ; Jahangier ZN; van der Laan WH; Bruyn GAW; Baudoin P; Wijngaarden S; Vos PAJM; Bos R; Starmans MJF; Griep EN; Griep-Wentink JRM; Allaart CF; Heurkens AHM; Teitsma XM; Tekstra J; Marijnissen ACA; Lafeber FPJ; Jacobs JWG
    Lancet; 2016 Jul; 388(10042):343-355. PubMed ID: 27287832
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reply to: methotrexate and not much harm to the lungs by H. Yazici.
    Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ
    Clin Exp Rheumatol; 2014; 32(6 Suppl 87):S-11. PubMed ID: 25233888
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of abatacept in patients with methotrexate-resistant active rheumatoid arthritis: a randomized trial.
    Kremer JM; Genant HK; Moreland LW; Russell AS; Emery P; Abud-Mendoza C; Szechinski J; Li T; Ge Z; Becker JC; Westhovens R
    Ann Intern Med; 2006 Jun; 144(12):865-76. PubMed ID: 16785475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Patient, disease, and therapy-related factors that influence discontinuation of disease-modifying antirheumatic drugs: a population-based incidence cohort of patients with rheumatoid arthritis.
    Maradit-Kremers H; Nicola PJ; Crowson CS; O'Fallon WM; Gabriel SE
    J Rheumatol; 2006 Feb; 33(2):248-55. PubMed ID: 16358365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival analysis of disease modifying antirheumatic drugs in Spanish rheumatoid arthritis patients.
    De La Mata J; Blanco FJ; Gómez-Reino JJ
    Ann Rheum Dis; 1995 Nov; 54(11):881-5. PubMed ID: 7492236
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of venous thromboembolism in patients with rheumatoid arthritis: initiating disease-modifying antirheumatic drugs.
    Kim SC; Solomon DH; Liu J; Franklin JM; Glynn RJ; Schneeweiss S
    Am J Med; 2015 May; 128(5):539.e7-17. PubMed ID: 25534420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and risk factors for low dose methotrexate toxicity: a cohort of 28 patients.
    Kivity S; Zafrir Y; Loebstein R; Pauzner R; Mouallem M; Mayan H
    Autoimmun Rev; 2014 Nov; 13(11):1109-13. PubMed ID: 25172240
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Side effects and management of side effects of methotrexate in rheumatoid arthritis.
    Albrecht K; Müller-Ladner U
    Clin Exp Rheumatol; 2010; 28(5 Suppl 61):S95-101. PubMed ID: 21044440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Reply: To PMID 24757133.
    Conway R; Coughlan RJ; Low C; O'Donnell MJ; Carey JJ
    Arthritis Rheumatol; 2014 Sep; 66(9):2642. PubMed ID: 24910377
    [No Abstract]   [Full Text] [Related]  

  • 30. Clinical characteristics of patients with rheumatoid arthritis and methotrexate induced pneumonitis.
    Ohosone Y; Okano Y; Kameda H; Fujii T; Hama N; Hirakata M; Mimori T; Akizuki M; Ikeda Y
    J Rheumatol; 1997 Dec; 24(12):2299-303. PubMed ID: 9415631
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The impact of C677T and A1298C MTHFR polymorphisms on methotrexate therapeutic response in East Bohemian region rheumatoid arthritis patients.
    Soukup T; Dosedel M; Pavek P; Nekvindova J; Barvik I; Bubancova I; Bradna P; Kubena AA; Carazo AF; Veleta T; Vlcek J
    Rheumatol Int; 2015 Jul; 35(7):1149-61. PubMed ID: 25618758
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pneumocystis carinii pneumonia in rheumatoid arthritis patients treated with methotrexate. A report of two cases.
    Roux N; Flipo RM; Cortet B; Lafitte JJ; Tonnel AB; Duquesnoy B; Delcambre B
    Rev Rhum Engl Ed; 1996 Jun; 63(6):453-6. PubMed ID: 8817757
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hematologic malignant neoplasms after drug exposure in rheumatoid arthritis.
    Bernatsky S; Clarke AE; Suissa S
    Arch Intern Med; 2008 Feb; 168(4):378-81. PubMed ID: 18299492
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicity profile of methotrexate in rheumatoid arthritis. A preliminary survey.
    Coleiro B; Mallia C
    Adv Exp Med Biol; 1999; 455():359-65. PubMed ID: 10599370
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular Risks of Hydroxychloroquine vs Methotrexate in Patients With Rheumatoid Arthritis.
    D'Andrea E; Desai RJ; He M; Glynn RJ; Lee H; Weinblatt ME; Kim SC
    J Am Coll Cardiol; 2022 Jul; 80(1):36-46. PubMed ID: 35772915
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methotrexate-induced lung injury in patients with rheumatoid arthritis occurs with peripheral blood lymphocyte count decrease.
    Inokuma S; Kono H; Kohno Y; Hiramatsu K; Ito K; Shiratori K; Yamazaki J; Nakayama H; Shoda H; Tanaka Y
    Ann Rheum Dis; 2006 Aug; 65(8):1113-4. PubMed ID: 16837494
    [No Abstract]   [Full Text] [Related]  

  • 37. Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.
    Mori S; Arima N; Ito M; Fujiyama S; Kamo Y; Ueki Y
    PLoS One; 2018; 13(8):e0203084. PubMed ID: 30142184
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapies for active rheumatoid arthritis after methotrexate failure.
    O'Dell JR; Mikuls TR; Taylor TH; Ahluwalia V; Brophy M; Warren SR; Lew RA; Cannella AC; Kunkel G; Phibbs CS; Anis AH; Leatherman S; Keystone E;
    N Engl J Med; 2013 Jul; 369(4):307-18. PubMed ID: 23755969
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of the associations between single nucleotide polymorphisms or haplotypes and responses to disease-modifying antirheumatic drugs in patients with rheumatoid arthritis: a proposal for prospective pharmacogenomic study in clinical practice.
    Taniguchi A; Urano W; Tanaka E; Furihata S; Kamitsuji S; Inoue E; Yamanaka M; Yamanaka H; Kamatani N
    Pharmacogenet Genomics; 2007 Jun; 17(6):383-90. PubMed ID: 17502830
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring methotrexate hepatic toxicity in rheumatoid arthritis: is it time to update the guidelines?
    Yazici Y; Erkan D; Paget SA
    J Rheumatol; 2002 Aug; 29(8):1586-9. PubMed ID: 12180713
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.